Tag: Cancer: Skin
Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i
UV Exposure Not Linked to Risk for Melanoma in Skin of Color
In 11 of 13 studies reviewed, no association observed between UV exposure, melanoma in skin of color
AI Model May Predict Immunotherapy Response in Melanoma
Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma
Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma
Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations
Follow-up Calls After Mohs Surgery Do Not Boost Satisfaction
But calls made the evening of dermatology surgery can identify patients with active pain
Topical Calcineurin Inhibitors Not Tied to Skin Cancer
No increased risk seen with topical calcineurin versus topical corticosteroids in adults with dermatitis
Malpractice Fears, Patient Safety Drive Skin Doctors to Order Extra Tests
In a survey, dermatopathologists cite patient safety, malpractice fears as reason to use extra patient services
U.S. Burden of Skin and Subcutaneous Diseases Increasing
Increases seen across all 50 states, with geographic variation in percentage
Vitamin D May Cut Colitis Risk for Immune Checkpoint Inhibitors
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma
Racial Differences Seen in Time to Treatment for Melanoma
Time from diagnosis to definitive surgery is twice as long on average for black versus white patients
